meglumine has been researched along with Asymptomatic Conditions in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, M; Balu, N; Cattaneo, M; Froio, A; Gallino, A; Gallino, JM; Limoni, C; Porretta, AP; Santini, P; Staub, D; Sun, J; Wyttenbach, R; Xu, D; Yuan, C | 1 |
Bazille, G; Jeung, MY; Ohana, M; Roy, C | 1 |
2 other study(ies) available for meglumine and Asymptomatic Conditions
Article | Year |
---|---|
Imaging of Carotid Plaque Neovascularization by Contrast-Enhanced Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Carotid Arteries; Carotid Stenosis; Contrast Media; Female; Humans; Magnetic Resonance Angiography; Male; Meglumine; Neovascularization, Pathologic; Organometallic Compounds; Phospholipids; Plaque, Atherosclerotic; Predictive Value of Tests; Sulfur Hexafluoride; Ultrasonography, Doppler, Duplex | 2019 |
Cerebral staging of lung cancer: is one single contrast-enhanced T1-weighted three-dimensional gradient-echo sequence sufficient?
Topics: Aged; Asymptomatic Diseases; Brain Neoplasms; Carcinoma; Contrast Media; Echo-Planar Imaging; Female; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Meglumine; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2014 |